Cambridge Commodities Ltd

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• FALSE1 refused line

  False or misleading labeling

  The labeling appeared to be false or misleading in some particular.

• LACKS FIRM1 refused line

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Cambridge Commodities Ltd

Is Cambridge Commodities Ltd on an FDA import alert?

Yes. As of October 25, 2026, Cambridge Commodities Ltd is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for sneak preworkout shake (gaming supplement); FDA published the listing on June 27, 2018.

Has FDA refused shipments from Cambridge Commodities Ltd?

Yes. FDA refused 1 shipment line from Cambridge Commodities Ltd on March 28, 2018. The most recent, on March 28, 2018, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as FALSE (false or misleading labeling).

Why did FDA refuse Cambridge Commodities Ltd's shipments?

The most frequent charges are FALSE (false or misleading labeling, 1 line) and LACKS FIRM (manufacturer name and address missing, 1 line).

When was Cambridge Commodities Ltd last inspected by FDA?

FDA's most recent inspection of Cambridge Commodities Ltd with a final classification is dated March 14, 2023 and was classified NAI (No Action Indicated).

What is Cambridge Commodities Ltd's FEI number?

Cambridge Commodities Ltd's FDA Establishment Identifier (FEI) is 3012681605.

Can shipments from Cambridge Commodities Ltd still enter the U.S.?

Shipments of sneak preworkout shake (gaming supplement) from Cambridge Commodities Ltd can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).